Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 053514/0780 | |
| Pages: | 9 |
| | Recorded: | 06/11/2020 | | |
| Attorney Dkt #: | 12-0438-US-1 |
| Conveyance: | CORRECTIVE ASSIGNMENT TO CORRECT THE ATTACHED SUPPORTING DOCUMENTS PREVIOUSLY RECORDED ON REEL 052890 FRAME 0642. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT. |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
|
Issue Dt:
|
02/14/2023
|
Application #:
|
16830322
|
Filing Dt:
|
03/26/2020
|
|
Publication #:
|
|
Pub Dt:
|
10/01/2020
| | | | |
|
Title:
|
LRP5 AND PD-1 ANTAGONIST ANTICANCER COMBINATION THERAPY
|
|
|
Assignee
|
|
|
|
|
| DR.-BOEHRINGER-GASSE 5-11, A-1121 |
| VIENNA, AUSTRIA |
|
|
Correspondence name and address
|
| |
BOEHRINGER INGELHEIM USA CORP.
|
| |
900 RIDGEBURY ROAD
|
| |
PO BOX 368
|
| |
RIDGEFIELD, CT 06877
|
Search Results as of:
06/08/2024 05:43 AM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
